Skip to main content

Press Releases

January 10, 2020
Washington, DC -- Representative Mikie Sherrill (NJ-11) voted today for H.R. 535, the PFAS Action Act of 2019, comprehensive, bipartisan legislation to address the public health threat from PFAS chemicals. Per- and poly- fluoroalkyl substances (PFAS) are a class of man-made chemicals that have been linked to adverse health effects including cancer, immune system effects, infertility, impaired child development, high cholesterol, and thyroid disease. Because of their strong atomic bonds, these are known as “forever chemicals” that are extremely persistent in the environment.
Image
Seal of the United States House of Representatives
January 9, 2020

Washington, DC -- Representative Mikie Sherrill (NJ-11) voted today to preserve congressional authority over the power to declare war and to pass H.Con.Res. 83.

Image
Chairwoman Sherrill at a House Science Investigations and Oversight Committee Hearing
January 9, 2020

Washington, DC -- Representative Mikie Sherrill (NJ-11) was unanimously chosen by her House Science, Space, and Technology Committee colleagues today to serve as Chairwoman of the Environment Subcommittee. The Subcommittee on Environment oversees environmental, climate change, and weather research.

Issues:Environment
Image
Seal of the United States House of Representatives
January 7, 2020
Washington, DC -- Today, Representative Mikie Sherrill (NJ-11) and Representative Lisa Blunt Rochester (DE-At Large) introduced H.R. 5542, the Mitigate Methane Now Act, legislation to encourage the replacement of old, home distribution pipelines which are a major source of methane leakage across the country and to help mitigate climate change immediately.
Issues:Environment
Image
Seal of the United States House of Representatives
January 4, 2020

Parsippany, NJ -- Representative Mikie Sherrill (NJ-11) released the following statement on the airstrike at Baghdad International Airport which killed Iranian military leader Qasem Soleimani:

December 20, 2019
Washington, DC – Representative Sherrill (NJ-11) voted today to pass H.R. 5430, the U.S.-Mexico-Canada Agreement (USMCA) Implementation Act. The USMCA makes critical improvements to the 25-year-old North American Free Trade Agreement (NAFTA) by strengthening enforcement, labor, and environmental provisions and ensuring that any changes put forward in the implementing legislation do not harm U.S. businesses, consumers, or workers.
December 19, 2019
Washington, DC – Representative Mikie Sherrill (NJ-11) fulfilled another key pledge today to residents in New Jersey by delivering House passage of a state and local tax (SALT) deduction bill. The bipartisan Restoring Tax Fairness for States and Localities Act (H.R. 5377) removes the marriage penalty for joint filers and restores the ability for taxpayers to deduct their state and local taxes from federal tax returns after 2020.
December 17, 2019

Washington, DC – Today, Representative Mikie Sherrill (NJ-11) applauded the House passage of the two bipartisan legislative packages that included all 12 fiscal year 2020 bills, fully funding the government and preventing a shutdown.

Image
Seal of the United States House of Representatives
December 17, 2019

Washington, DC – Representative Mikie Sherrill (NJ-11) issued the following statement on the Articles of Impeachment:

"I have served this country most of my life, both in uniform and out, here at home and abroad, in wartime and in peace. I have been honored to enter into service once again in the United States House of Representatives.

December 12, 2019
Washington, DC -- Representative Mikie Sherrill (NJ-11) voted today to slash costs for prescription drugs for New Jersey families and seniors. The bipartisan Lower Drug Costs Now Act of 2019 (H.R. 3) gives Medicare the power to negotiate directly with drug companies and creates a new, $2,000 out-of-pocket limit on prescription drug costs for Medicare beneficiaries. Sherrill had a direct hand in the bill’s text, successfully including her legislation to direct a $10 billion investment in the National Institutes of Health for cancer, rare diseases, and antibiotic resistance research. Savings from H.R. 3 will be used to fund this $10 billion investment.
Issues:Health